Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s displayed release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a site-level version change rather than a modification to the clinical study record.
    Difference
    0.1%
    Check dated 2026-04-23T22:10:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:37.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a Medullary thyroid carcinoma topic entry and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T06:59:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:20:12.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:00.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added and the previous Revision: v3.4.1 tag was removed; no study content, eligibility criteria, or navigation changes are evident.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.